BSD receives FDA review questions for Phase II MTX-180 Microwave Ablation System 510(k) submission
Links shared publicly online about this topic.
- 1,027total visits
BSD receives FDA review questions for Phase II MTX-180 Microwave Ablation System 510(k) submission
BSD Medical Corporation today announced that it has received review questions from the U.S. Food and Drug Administration (FDA) regarding the 510(k) submission the Company filed for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System (MTX-180) for ablation of soft tissue.
View full resource at news-medical.net
Most Recently Shared on July 12, 2010 at 5:46 pm By:
Oncology News: BSD receives FDA review questions for Phase II MTX-180 Microwave Ablation System 510(k) submission:... http://bit.ly/asnM3a
Advertisement
